Term
|
Definition
| Insulin or a combination of orals |
|
|
Term
| Drugs that lower A1C 1-2% |
|
Definition
Metformin
SFU
GLP1 Receptor Antagonist
TZD |
|
|
Term
| Drugs that lower A1C 0.6-1% |
|
Definition
DPP4 Inhibitors
SGLT2 Inhibitors |
|
|
Term
| Drugs that lower A1C<0.6% |
|
Definition
Alpha-Glucosidase Inhibitors
Dopamine Agonist
BAS |
|
|
Term
| MEds that work only on FG blood glucose |
|
Definition
Metformin
TZD
SGLT2 Inhibitors
Basal Insulin |
|
|
Term
| Meds that work on PG blood glucose |
|
Definition
Alpha-Glucosidase Inhibitors
DPP4 Inhibitors
Meglitinides
GLP1 Receptor Antagonist
Bolus Insulin |
|
|
Term
| MEds that work on FG and PG |
|
Definition
|
|
Term
| Meds that directly cause an insulin release from the pancreas |
|
Definition
|
|
Term
| Meds that indirectly cause a release of insulin from the pancreas |
|
Definition
|
|
Term
| Meds that do not cause a release of insulin from the pancreas |
|
Definition
Metformin
TZD
Alpha glucosidase inhibitors
BAS
Dopamine Agonist
SGLT2 inhibitors |
|
|
Term
| Meds that reduce Cardiac events |
|
Definition
Metformin
Empagliflozin
Liraglutide
Bromocriptine |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Meds that help with weight loss |
|
Definition
Amylin
GLP1 RA
SGLT2-I
Metformin |
|
|
Term
| Meds with a risk of pancreatitis |
|
Definition
|
|
Term
| Meds with s/e of lactic acidosis |
|
Definition
|
|
Term
| Meds that need B12 monitoring |
|
Definition
|
|
Term
| Meds with a risk of bone fracture |
|
Definition
|
|
Term
|
Definition
|
|
Term
| Drugs that need to be renally dosed |
|
Definition
SFU
Exenatide
DPP4 except lina |
|
|
Term
| Meds with a risk of weight gain |
|
Definition
|
|
Term
| Meds with a high risk f UTI |
|
Definition
|
|
Term
| Meds that are only available injectable |
|
Definition
|
|
